These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3237074)

  • 1. C1 inhibitor: the predominant inhibitor of plasma kallikrein.
    Schapira M; de Agostini A; Colman RW
    Methods Enzymol; 1988; 163():179-85. PubMed ID: 3237074
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor.
    Ravindran S; Grys TE; Welch RA; Schapira M; Patston PA
    Thromb Haemost; 2004 Dec; 92(6):1277-83. PubMed ID: 15583734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 inhibitor.
    Davis AE; Aulak KS; Zahedi K; Bissler JJ; Harrison RA
    Methods Enzymol; 1993; 223():97-120. PubMed ID: 8271970
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of plasma kallikrein with plasma proteinase inhibitors.
    Salvesen G; Virca GD; Travis J
    Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M; Longo J; Kaplan AP
    J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of plasma kallikrein with the C1 inhibitor.
    Gigli I; Mason JW; Colman RW; Austen KF
    J Immunol; 1970 Mar; 104(3):574-81. PubMed ID: 5435787
    [No Abstract]   [Full Text] [Related]  

  • 8. C1 inhibitor: the main inhibitor of human plasma kallikrein.
    Trumpi-Kalshoven MM; Kluft C
    Adv Biosci; 1978 Jul; 17():93-101. PubMed ID: 90628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measurement of plasma kallikrein inhibitor using purified human plasma kallikrein].
    Haneda Y; Denpo Y; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1983 Mar; 24(3):225-31. PubMed ID: 6193294
    [No Abstract]   [Full Text] [Related]  

  • 10. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass.
    Wachtfogel YT; Harpel PC; Edmunds LH; Colman RW
    Blood; 1989 Feb; 73(2):468-71. PubMed ID: 2917186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays.
    Gallimore MJ; Amundsen E; Larsbraaten M; Lyngaas K; Fareid E
    Thromb Res; 1979; 16(5-6):695-703. PubMed ID: 93313
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of human plasma kallikrein and its light chain with C1 inhibitor.
    van der Graaf F; Koedam JA; Griffin JH; Bouma BN
    Biochemistry; 1983 Sep; 22(20):4860-6. PubMed ID: 6556071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
    Veloso D; Tseng SY; Craig AR; Colman RW
    Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
    [No Abstract]   [Full Text] [Related]  

  • 15. Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor.
    Killeen AA; Meyer KC; Vogt JM; Edson JR
    Am J Clin Pathol; 1987 Aug; 88(2):223-8. PubMed ID: 3113230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of kallikrein in human plasma.
    McConnell DJ
    J Clin Invest; 1972 Jul; 51(7):1611-23. PubMed ID: 4113391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravascular ionic and non-ionic radiographic contrast agents on parameters of the kallikrein-kinin-system.
    Hoffmeister HM; Fuhrer G; Abels GA; Heller W
    Adv Exp Med Biol; 1989; 247A():477-80. PubMed ID: 2513707
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of a proteinase inhibitor from bovine serum with C1-inhibitor activity.
    Van Nostrand WE; Cunningham DD
    Biochim Biophys Acta; 1987 Feb; 923(2):167-75. PubMed ID: 3814612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.